HER3-Targeted Drug Active in Advanced/Metastatic Breast Cancer
Durable responses across all three major subtypes of breast cancer
Source: medpagetoday.com
Iane Krop News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Iane Krop. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Iane Krop Today - Breaking & Trending Today
Delivering on the promise of personalized bre
Researchers have developed a strategy to predict the most likely response of a cancer to a specific less toxic treatment regimen.
Source: eurekalert.org
Delivering on the promise of personalized breast cancer therapy
A team led by researchers at Baylor College of Medicine is coming closer to delivering on the promise of personalized breast cancer therapy with a
Source: nationaltribune.com.au
Daiichi Sankyo: Patritumab Deruxtecan Continues to Show Promising Clinical Activity in Patients Across Subtypes of Metastatic Breast or Lung Cancer
Data from a phase 1/2 trial in patients with several subtypes of HER3 expressing metastatic breast cancer featured as oral presentation at ASCO First presentation of phase 1 data from a cohort
Source: finanznachrichten.de
Daiichi Sankyo: Datopotamab Deruxtecan Continues to Show Promising Durable Response and Disease Control in Patients with Metastatic Triple Negative Breast Cancer
Updated data from the TNBC cohort of the TROPION-PanTumor01 phase 1 trial of Daiichi Sankyo and AstraZeneca's datopotamab deruxtecan featured as oral presentation at SABCS New data from the TROPION-PanTumor01
Source: finanznachrichten.de